Ross J. Baldessarini
Ross J. Baldessarini (born 1937, Western Massachusetts),[1] a psychopharmacologist, is the Director, International Consortium for Bipolar & Psychotic Disorders Research at McLean Hospital and Professor of Psychiatry (Neuroscience) at Harvard Medical School.[2]
Education
- 1959 AB in Chemistry, Williams College
- 1963 MD, Johns Hopkins University School of Medicine[2]
Publications
Books
Chemotherapy in Psychiatry: Pharmacologic Basis of Treatments for Major Mental Illness
Selected journal articles
- Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment of bipolar depression. International Journal of Neuropsychopharmacology 2013;16(7):1673-1685.
- Yildiz A, Vieta E, Nikodem M, Correll CU, Baldessarini RJ. A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine 2014;1–19.
- Schalkwijk S, Undurraga J, Tondo L, Baldessarini RJ. Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. International Journal of Neuropsychopharmacology 2014;17(8):1343-1352.
References
- "Ross J. Baldessarini, M.D., M.A. (hon.), D.Sc. (hon.), DLFAPA, FACP, FACNP, FCINP". International Network for the History of Neuropsychopharmacology. Retrieved 25 June 2021.
- "Ross J. Baldessarini, MD". McLean Hospital. Retrieved 25 June 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.